Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma

BACKGROUND: Clinical trials have recently evaluated safety and efficacy of neoadjuvant therapy among patients with surgically resectable regional melanoma metastases. To capture informative prognostic data connected to pathological response in such trials, it is critical to standardize pathologic as...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Oncol
Asıl Yazarlar: Tetzlaff, M T, Messina, J L, Stein, J E, Xu, X, Amaria, R N, Blank, C U, van de Wiel, B A, Ferguson, P M, Rawson, R V, Ross, M I, Spillane, A J, Gershenwald, J E, Saw, R P M, van Akkooi, A C J, van Houdt, W J, Mitchell, T C, Menzies, A M, Long, G V, Wargo, J A, Davies, M A, Prieto, V G, Taube, J M, Scolyer, R A
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6096739/
https://ncbi.nlm.nih.gov/pubmed/29945191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdy226
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller